Johnson & Johnson
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Johnson & Johnson
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2024 Revenue
$88.8B
▲ 4.3% vs FY2023 ($85.2B)
Net Income: $13.3B
Source: Annual report / company filing
Johnson & Johnson reported $88.8B in revenue for fiscal year 2024. This represents a growth of 4.3% compared to the 2023 figure of $85.2B. In 2025, revenue increased to $94.2B.
Post-spinoff net sales rose about 4.3% to $88.821 billion in 2024, with growth in the Innovative Medicine oncology franchise helping offset early Stelara biosimilar erosion.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $94.2B | — | +6.0% |
| FY2024 | $88.8B | $13.3B | +4.3% |
| FY2023 | $85.2B | — | -9.2% |
| FY2022 | $93.8B | — | +0.0% |
| FY2021 | $93.8B | — | +13.6% |
| FY2020 | $82.6B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.